Search research articles
Contact Us
Filters
Showing results (101-110 of 143) with videos related to
Page
of 15
Sort By:
Journal of Cancer
|
October 6, 2010
Mesothelin as a potential therapeutic target in human cholangiocarcinoma
Liping Yu, Mingqian Feng, Heungnam Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 9, 2013
Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma
Mingqian Feng, Wei Gao, Ruoqi Wang, et al.
Molecular Cancer Therapeutics
|
February 2, 2013
A human single-domain antibody elicits potent antitumor activity by targeting an epitope in mesothelin close to the cancer cell surface
Zhewei Tang, Mingqian Feng, Wei Gao, et al.
Journal of Translational Medicine
|
August 5, 2020
32A9, a novel human antibody for designing an immunotoxin and CAR-T cells against glypican-3 in hepatocellular carcinoma
Xiaoyu Liu, Fang Gao, Longwei Jiang, et al.
Bioconjugate Chemistry
|
August 22, 2024
Sortase-Mediated Site-Specific Conjugation to Prepare Fluorine-18-Labeled Nanobodies
Falguni Basuli, Jianfeng Shi, Eric Lindberg, et al.
Molecular Cancer Therapeutics
|
May 2, 2022
Development of Highly Effective Anti-Mesothelin hYP218 Chimeric Antigen Receptor T Cells With Increased Tumor Infiltration and Persistence for Treating Solid Tumors
Sakshi Tomar, Jingli Zhang, Manakamana Khanal, et al.
Biorxiv : the Preprint Server for Biology
|
May 7, 2026
Allogeneic CRISPR-Engineered CAR-T Cells Drive Potent Antitumor Activity in Solid Tumors
Mingyu Huo, Dan Li, Nan Li, et al.
Nature Reviews. Cancer
|
May 13, 2024
Cancer therapy with antibodies
Suman Paul, Maximilian F Konig, Drew M Pardoll, et al.
Nanomedicine (London, England)
|
May 2, 2015
Photoimmunotherapy of hepatocellular carcinoma-targeting Glypican-3 combined with nanosized albumin-bound paclitaxel
Hirofumi Hanaoka, Takahito Nakajima, Kazuhide Sato, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
August 20, 2019
<i>In Vitro</i> Performance of Published Glypican 3-Targeting Peptides TJ12P1 and L5 Indicates Lack of Specificity and Potency
Rose M Berman, Olivia J Kelada, Nicholas T Gutsche, et al.
Page
of 15
Search research articles
Search
Showing results (101-110 of 143) with videos related to
Sort By:
Page
of 15
Journal of Cancer
|
October 6, 2010
Mesothelin as a potential therapeutic target in human cholangiocarcinoma
Liping Yu, Mingqian Feng, Heungnam Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 9, 2013
Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma
Mingqian Feng, Wei Gao, Ruoqi Wang, et al.
Molecular Cancer Therapeutics
|
February 2, 2013
A human single-domain antibody elicits potent antitumor activity by targeting an epitope in mesothelin close to the cancer cell surface
Zhewei Tang, Mingqian Feng, Wei Gao, et al.
Journal of Translational Medicine
|
August 5, 2020
32A9, a novel human antibody for designing an immunotoxin and CAR-T cells against glypican-3 in hepatocellular carcinoma
Xiaoyu Liu, Fang Gao, Longwei Jiang, et al.
Bioconjugate Chemistry
|
August 22, 2024
Sortase-Mediated Site-Specific Conjugation to Prepare Fluorine-18-Labeled Nanobodies
Falguni Basuli, Jianfeng Shi, Eric Lindberg, et al.
Molecular Cancer Therapeutics
|
May 2, 2022
Development of Highly Effective Anti-Mesothelin hYP218 Chimeric Antigen Receptor T Cells With Increased Tumor Infiltration and Persistence for Treating Solid Tumors
Sakshi Tomar, Jingli Zhang, Manakamana Khanal, et al.
Biorxiv : the Preprint Server for Biology
|
May 7, 2026
Allogeneic CRISPR-Engineered CAR-T Cells Drive Potent Antitumor Activity in Solid Tumors
Mingyu Huo, Dan Li, Nan Li, et al.
Nature Reviews. Cancer
|
May 13, 2024
Cancer therapy with antibodies
Suman Paul, Maximilian F Konig, Drew M Pardoll, et al.
Nanomedicine (London, England)
|
May 2, 2015
Photoimmunotherapy of hepatocellular carcinoma-targeting Glypican-3 combined with nanosized albumin-bound paclitaxel
Hirofumi Hanaoka, Takahito Nakajima, Kazuhide Sato, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
August 20, 2019
<i>In Vitro</i> Performance of Published Glypican 3-Targeting Peptides TJ12P1 and L5 Indicates Lack of Specificity and Potency
Rose M Berman, Olivia J Kelada, Nicholas T Gutsche, et al.
Page
of 15